Methods to enhance smoking cessation after myocardial infarction

被引：19

作者：

Goldstein, MG

Niaura, R

机构：

[1] Bayer Inst Hlth Care Commun, West Haven, CT 06516 USA

[2] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA

[3] Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2000年 / 84卷 / 01期

关键词：

D O I：

10.1016/S0025-7125(05)70207-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The evidence linking smoking and coronary artery disease is quite strong, and there is also a positive relationship between smoking cessation and reduction in cardiovascular disease risk. Nicotine replacement therapy and bupropion are effective treatments for smoking cessation and are most effective when combined with behavioral counseling. intensive multicomponent interventions that include a case-management component have produced the highest smoking cessation rates for patients who suffer a myocardial infarction.

引用

页码：63 / +

页数：19

共 70 条

[1]

[Anonymous], CLIN MANAGEMENT NICO

[2]

[Anonymous], 1983, HLTH CONS SMOK CARD

[3] SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL [J].

BARBASH, GI ;

WHITE, HD ;

MODAN, M ;

DIAZ, R ;

HAMPTON, JR ;

HEIKKILA, J ;

KRISTINSSON, A ;

MOULOPOULOS, S ;

ERNESTO ;

PAOLASSO ;

VANDERWERF, T ;

PEHRSSON, K ;

SANDOE, E ;

SIMES, J ;

WILCOX, RG ;

VERSTRAETE, M ;

VONDERLIPPE, G ;

VANDEWERF, F .

CIRCULATION, 1993, 87 (01) :53-58

[4]

BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318

[5] REGIONAL DEPOSITION OF INHALED C-11 NICOTINE VAPOR IN THE HUMAN AIRWAY AS VISUALIZED BY POSITRON EMISSION TOMOGRAPHY [J].

BERGSTROM, M ;

NORDBERG, A ;

LUNELL, E ;

ANTONI, G ;

LANGSTROM, B .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :309-317

[6] SMOKING FOLLOWING MYOCARDIAL-INFARCTION - A CRITICAL-REVIEW OF THE LITERATURE [J].

BURLING, TA ;

SINGLETON, EG ;

BIGELOW, GE ;

BAILE, WF ;

GOTTLIEB, SH .

HEALTH PSYCHOLOGY, 1984, 3 (01) :83-96

[7]

Castelli, 1984, J CARDIAC REHABIL, V4, P267

[8] HEPARIN KINETICS - VARIABLES RELATED TO DISPOSITION AND DOSAGE [J].

CIPOLLE, RJ ;

SEIFERT, RD ;

NEILAN, BA ;

ZASKE, DE ;

HAUS, E .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :387-393

[9] A CASE-MANAGEMENT SYSTEM FOR CORONARY RISK FACTOR MODIFICATION AFTER ACUTE MYOCARDIAL-INFARCTION [J].

DEBUSK, RF ;

MILLER, NH ;

SUPERKO, HR ;

DENNIS, CA ;

THOMAS, RJ ;

LEW, HT ;

BERGER, WE ;

HELLER, RS ;

ROMPF, J ;

GEE, D ;

KRAEMER, HC ;

BANDURA, A ;

GHANDOUR, G ;

CLARK, M ;

SHAH, RV ;

FISHER, L ;

TAYLOR, CB .

ANNALS OF INTERNAL MEDICINE, 1994, 120 (09) :721-729

[10] SMOKING - HEALTH-EFFECTS AND CONTROL .1. [J].

FIELDING, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (08) :491-498

← 1 2 3 4 5 6 7 →